How big is the North America Genetic Testing Market?

The North America Genetic Testing Market size is expected to reach USD 7.78 billion in 2024 and grow at a CAGR of 10.02% to reach USD 12.54 billion by 2029. Read More

What is the current North America Genetic Testing Market size?

In 2024, the North America Genetic Testing Market size is expected to reach USD 7.78 billion. Read More

Who are the key players in North America Genetic Testing Market?

Abbott Laboratories, Illumina Inc., 23&Me Inc., F Hoffmann-La Roche Ltd and Danaher Corporation (Cepheid Inc.) are the major companies operating in the North America Genetic Testing Market. Read More

What years does this North America Genetic Testing Market cover, and what was the market size in 2023?

In 2023, the North America Genetic Testing Market size was estimated at USD 7.07 billion. The report covers the North America Genetic Testing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Genetic Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Genetic Testing Market Share

Statistics for the 2023 & 2024 North America Genetic Testing market share, created by Mordor Intelligence™ Industry Reports. North America Genetic Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of North America Genetic Testing Industry

The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. These include 23&Me Inc., Abbott Laboratories, Ariosa Diagnostics Inc., Danaher Corporation (Cepheid Inc.), Illumina Inc., DiaSorin Spa (Luminex Corporation), Biorad Laboratories Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, and F Hoffmann-La Roche Ltd.